Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2021-12-28 Capital/Financing Update
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
公告本公司暨重要子公司Alvogen Korea Co., Ltd.共同 召開重大訊息記者會之新聞稿
Capital/Financing Update Classification · 95% confidence The document is a company announcement from 美時 (stock code 1795) regarding a significant investment in Alvogen Pharma Limited, including details about the investment amount, terms, and strategic implications. It is a news release about a capital investment and financing activity, not a financial report, earnings release, or regulatory filing. The document length is short (1432 characters) and contains detailed information about a financing transaction. Therefore, it fits best under Capital/Financing Update (CAP).
2021-12-28 Chinese
公告本公司暨重要子公司Alvogen Korea Co., Ltd.取得Alvogen Pharma Limited特別股股權
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about a transaction involving the acquisition of preferred shares by the company and its subsidiary. It includes specifics such as transaction dates, amounts, share quantities, related parties, board approvals, and accounting firm details. The content focuses on a capital investment and strategic alliance, describing the terms and conditions of the share acquisition. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a brief announcement of voting results or a regulatory compliance filing without substantive content. Given the detailed nature of the transaction and its focus on financing activities, this fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains detailed transaction data rather than just a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2021-12-28 Chinese
110年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and stock ownership information of company insiders, including directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholdings and transactions, not on financial results, management changes, or meeting materials. There is no indication of a full financial report, earnings release, or meeting announcement. The document is a report of personal share transactions and holdings by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is substantial and contains detailed data, confirming it is the report itself, not an announcement or certification.
2021-12-14 Chinese
110年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings and pledged shares by company insiders, including directors, independent directors, general manager, deputy general managers, and major shareholders. It lists the number of shares held, pledged shares, and related percentages. The document does not contain financial statements, earnings data, or management discussion. It is a report on insider shareholdings and pledges, which corresponds to disclosures about personal share transactions or holdings by company directors and executives. This matches the definition of Director's Dealing (DIRS). The document length is 3653 characters, which is relatively short but contains detailed insider shareholding data, not just an announcement or a certification. Therefore, the best classification is DIRS with high confidence.
2021-12-14 Chinese
110年12月變更登記
Share Issue/Capital Change Classification · 95% confidence The document is a brief disclosure of the company's capital stock details, including authorized capital, paid-in capital, and changes in capital such as cancellation of restricted employee shares. It contains no financial statements, no management discussion, no earnings data, and no meeting or voting information. The document is short (852 characters) and appears to be a regulatory disclosure about capital structure or share capital changes. It does not fit the definition of a full report like Annual Report (10-K) or Interim Report (IR). It is not an announcement of a report publication. The content aligns best with a Share Issue/Capital Change announcement (SHA), as it details capital stock changes and approvals related to capital.
2021-12-10 Chinese
本公司收回已發行限制員工權利新股註銷減資變更登記完成
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement from a listed company (1795 美時) regarding the completion of a capital reduction registration after canceling restricted employee shares. It includes specific details about the capital amount before and after reduction, share counts, and net asset value per share. The document is short (932 characters) and focuses on a capital structure change rather than a full financial report. There is no indication of detailed financial statements or comprehensive analysis. This fits the category of a Share Issue/Capital Change announcement rather than a full Annual Report or Interim Report. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2021-12-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.